Patents Assigned to Lion Corporation
  • Publication number: 20210009500
    Abstract: A method for producing a fatty acid polyoxyethylene methyl ether in which ethylene oxide is added to a fatty acid methyl ester component comprising, as a main component, a fatty acid methyl ester having a fatty acid residue of 18 to 22 carbon atoms, the addition being conducted in the presence of a composite metal oxide catalyst and at least one alcohol selected from the group consisting of diethylene glycol, ethylene glycol, propylene glycol, ethanol, methanol and isopropyl alcohol.
    Type: Application
    Filed: December 20, 2018
    Publication date: January 14, 2021
    Applicant: Lion Corporation
    Inventors: Akinori JOKO, Masahiro SATO, Fumiya NIIKURA
  • Publication number: 20200375570
    Abstract: Provided is a testing method for determining an oral indicator by which an oral indicator can be determined. The testing method for determining an oral indicator includes an image acquisition step of acquiring an ultrasonic image of an inside of an attached gingiva of a subject, using a measurement probe, an average brightness acquisition step of acquiring average brightness of the ultrasonic image, and an indicator determination step of determining an oral indicator of the subject by referring to the average brightness and a reference of an oral indicator.
    Type: Application
    Filed: February 26, 2019
    Publication date: December 3, 2020
    Applicant: LION CORPORATION
    Inventors: Tsuguno YAMAGUCHI, Shinsuke KATAOKA
  • Patent number: 10472593
    Abstract: A liquid detergent of the present invention contains: component (a): a nonionic surfactant which contains compounds represented by the following formula (1) wherein an average value of m in formula (1) ranges from 5 to 20; and in which a ratio of the compound wherein R1 is a double bond-containing unsaturated hydrocarbon group is equal to or greater than 45% by mass with respect to a total amount of the component (a), and a ratio of the compound wherein R1 is an unsaturated hydrocarbon group having two or more double bonds is equal to or greater than 4% by mass with respect to a total amount of the compounds of formula (1) wherein R1 is an unsaturated hydrocarbon group; and component (b): an anionic surfactant. R1CO(EO)mOR2??(1) wherein R1 is a saturated or unsaturated hydrocarbon group having 15 to 17 carbon atoms; EO is an oxyethylene group; m is a positive integer; and R2 is an alkyl group having 1 to 3 carbon atoms.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: November 12, 2019
    Assignee: Lion Corporation
    Inventors: Yuka Morimoto, Takayasu Kubozono, Akinori Joko, Atsunori Morigaki
  • Patent number: 10407645
    Abstract: A coated ?-sulfofatty acid alkyl ester salt particle group containing ?-sulfofatty acid alkyl ester salt particles (A) and a zeolite particle group-containing coating component (B) with which the particles (A) are coated, in which the zeolite particle group is a zeolite particle group (b1) having a mean particle size of equal to or greater than 0.8 ?m and less than 3.8 ?m.
    Type: Grant
    Filed: October 1, 2015
    Date of Patent: September 10, 2019
    Assignee: Lion Corporation
    Inventors: Yoichi Ebashi, Yohei Nogami, Takashi Kobayashi, Kensuke Itakura, Kenji Morimura, Masashi Hara, Hideaki Watanabe
  • Patent number: 10315189
    Abstract: Disclosed is an ethoxylation catalyst having a BET specific surface area of 40 to 150 m2/g and including calcium sulfate particles including at least one kind of compound selected from the group consisting of calcium sulfate 0.5 hydrate and type III anhydrous calcium sulfate.
    Type: Grant
    Filed: September 5, 2016
    Date of Patent: June 11, 2019
    Assignee: Lion Corporation
    Inventor: Fumiya Niikura
  • Patent number: 10168339
    Abstract: It is an object of the present invention to provide a marker substance capable of accurately determining a risk of developing metabolic syndrome in vivo. That is, the present invention provides the followings: a marker peptide for determining the risk of developing the metabolic syndrome; an antibody or an aptamer bound to the marker peptide for determining the risk of developing the metabolic syndrome; a microarray in which the antibody or the aptamer bound to the marker peptide for determining the risk of developing the metabolic syndrome has been immobilized on a carrier; a method for determining the risk of developing the metabolic syndrome, comprising measuring an amount or the presence or absence of the marker peptide for determining the risk of developing the metabolic syndrome in a biological sample collected from a subject; and a kit for determining the risk of developing the metabolic syndrome, comprising the antibody or the aptamer or comprising the microarray.
    Type: Grant
    Filed: December 27, 2012
    Date of Patent: January 1, 2019
    Assignee: LION CORPORATION
    Inventors: Chiyoko Uchiyama, Kei Kurita, Eriko Fukushima, Riichi Maki
  • Patent number: 9982222
    Abstract: A detergent composition containing an ?-sulfo fatty acid alkyl ester salt and a fragrance composition, wherein the amount of the ?-sulfo fatty acid alkyl ester salt is from 1 to 30% by mass relative to the total mass of the detergent composition, the fragrance composition contains a fragrance (A) described below, and the amount of the fragrance (A) is from 0.07 to 0.5% by mass relative to the total mass of the detergent composition. Fragrance (A): a fragrance composed of at least one fragrance component selected from the group consisting of dihydromyrcenol, isobornyl acetate, ?-hexyl cinnamic aldehyde, lilial, tetrahydrolinalool, amyl salicylate, verdox, vertenex, tricyclodecenyl acetate, tricyclodecenyl propionate, Iso E Super and habanolide.
    Type: Grant
    Filed: June 12, 2014
    Date of Patent: May 29, 2018
    Assignee: Lion Corporation
    Inventors: Makoto Makino, Atsushi Tsuda, Takuya Tsutsui
  • Patent number: 9970946
    Abstract: The object of the present invention is to provide a marker substance capable of determining a risk of hyperglycemia in vivo with high accuracy. The present invention provides the following: a marker peptide for determining the risk of hyperglycemia; an antibody or an aptamer bound to the marker peptide for determining the risk of hyperglycemia; a microarray wherein the antibody or the aptamer to be bound to the marker peptide for determining the risk of hyperglycemia has been immobilized onto a carrier; a method of determining the risk of hyperglycemia wherein an amount or the presence/absence of the marker peptide for determining the risk of hyperglycemia is measured in a biological sample collected from a subject; and a kit for determining the risk of hyperglycemia comprising the antibody or the aptamer, or the microarray.
    Type: Grant
    Filed: December 10, 2013
    Date of Patent: May 15, 2018
    Assignee: LION CORPORATION
    Inventors: Chiyoko Uchiyama, Kei Kurita
  • Patent number: 9914900
    Abstract: This liquid detergent contains an ?-sulfofatty acid ester salt (component (a)), an alkylbenzene sulfonate (component (b)), a polyoxyethylene alkyl ether sulfate (component (c)), and an alkanolamine (component (d)). The amount of the component (a) is 5% by mass or greater; the total amount of the component (b) and the component (c) is 5% by mass or greater; the total amount of the component (a), the component (b), and the component (c) is 10% by mass to 50% by mass, the mass ratio represented by (d)/(a) is 1/5 or greater, and the mass ratio represented by (a)/((b)+(c)) is 1 or less.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: March 13, 2018
    Assignee: Lion Corporation
    Inventors: Atsunori Morigaki, Hiroshi Kimura, Hiroshi Konta
  • Patent number: 9719049
    Abstract: A surfactant solution of the present invention includes a component (a): an ?-sulfonated fatty acid ester salt; a component (b): an alkanolamine; a component (c): an aromatic sulfonic acid; and a component (d): water, wherein the content of the component (a) is within a range from 30 to 45 mass %, the molar ratio represented by (b)/(a) is within a range from 0.05 to 0.5, and the molar ratio represented by (b)/(c) is within a range from 0.5 to 2.
    Type: Grant
    Filed: October 31, 2014
    Date of Patent: August 1, 2017
    Assignee: Lion Corporation
    Inventors: Atsunori Morigaki, Nobukazu Shogase
  • Patent number: 9708252
    Abstract: The invention provides a fatty acid alkyl ester sulfonate metal salt mixture of (a) a fatty acid alkyl ester sulfonate metal salt having an endothermic peak area at 50 to 130° C. of less than 50% relative to the whole endothermic peak area at 0 to 130° C. as measured on a differential scanning calorimeter, and (b) a fatty acid alkyl ester sulfonate metal salt having an endothermic peak area at 50 to 130° C. of 50% or more relative to the whole endothermic peak area at 0 to 130° C. as measured on a differential scanning calorimeter, with a ratio of (a) to (b) by mass of 95/5 or less. The mixture of the invention is excellent in anti-caking properties.
    Type: Grant
    Filed: April 22, 2010
    Date of Patent: July 18, 2017
    Assignee: LION CORPORATION
    Inventors: Daisuke Negishi, Masahiko Matsubara, Yuki Nishiyama, Kensuke Itakura, Kenji Morimura
  • Patent number: 9510613
    Abstract: A panaxadiol-containing composition, containing: panaxadiol; and at least one of sucrose fatty acid ester and lecithin.
    Type: Grant
    Filed: April 16, 2012
    Date of Patent: December 6, 2016
    Assignee: LION CORPORATION
    Inventors: Yusuke Takamura, Mitsuru Nomura, Hideaki Iwasaki
  • Patent number: 9480672
    Abstract: An object of the present invention is to provide an internal composition capable of exerting various physiological functions such as a brain-function improving function. That is, the present invention provides an internal composition including docosahexaenoic acid and capsanthin, or docosahexaenoic acid, capsanthin, lutein, and zeaxanthin as active ingredients.
    Type: Grant
    Filed: July 10, 2014
    Date of Patent: November 1, 2016
    Assignee: LION CORPORATION
    Inventors: Hiroki Takenaka, Yasuharu Ishihara, Naoki Ichiyanagi, Misato Koakutsu, Kei Kurita
  • Patent number: 9457001
    Abstract: An object of the present invention is to provide an internal composition capable of exerting various physiological functions such as a brain-function improving function. That is, the present invention provides an internal composition including docosahexaenoic acid and capsanthin, or docosahexaenoic acid, capsanthin, lutein, and zeaxanthin as active ingredients.
    Type: Grant
    Filed: July 10, 2014
    Date of Patent: October 4, 2016
    Assignee: LION CORPORATION
    Inventors: Hiroki Takenaka, Yasuharu Ishihara, Naoki Ichiyanagi, Misato Koakutsu, Kei Kurita
  • Publication number: 20160067203
    Abstract: An object of the present invention is to provide an internal composition capable of exerting various physiological functions such as a brain-function improving function. That is, the present invention provides an internal composition including docosahexaenoic acid and capsanthin, or docosahexaenoic acid, capsanthin, lutein, and zeaxanthin as active ingredients.
    Type: Application
    Filed: July 10, 2014
    Publication date: March 10, 2016
    Applicant: LION CORPORATION
    Inventors: Hiroki TAKENAKA, Yasuharu ISHIHARA, Naoki ICHIYANAGI, Misato KOAKUTSU, Kei KURITA
  • Patent number: 9157183
    Abstract: The present invention provides a treatment agent composition for fiber products capable of producing an exceptional odor-eliminating and odor-preventing effect against various odors. This treatment agent composition for fiber products comprises: (A) highly branched cyclic dextrin; (B) at least one compound selected from the group consisting of an amine compound having within each molecule one to three C10-26 hydrocarbon groups optionally split with an ester group or an amide group, a salt of the amine compound, and a quaternized form of the amine compound; and (C) at least one compound selected from (C-1)-(C-3) below: (C-1) a fatty acid expressed by RaCOOH (Ra is a fatty acid represented by a C8-35 alkyl or alkenyl group), (C-2) a silicone compound, and (C-3) an aliphatic alcohol represented by RbOH (Rb is an aliphatic alcohol represented by a C8-35 alkyl or alkenyl group).
    Type: Grant
    Filed: May 27, 2013
    Date of Patent: October 13, 2015
    Assignee: LION CORPORATION
    Inventors: Tomohiko Amatani, Eiji Ogura, Ryo Hashimoto, Rie Adachi, Emiko Hashimoto, Naoyuki Egawa
  • Publication number: 20150285821
    Abstract: The object of the present invention is to provide a marker substance capable of determining a risk of hyperglycemia in vivo with high accuracy. The present invention provides the following: a marker peptide for determining the risk of hyperglycemia; an antibody or an aptamer bound to the marker peptide for determining the risk of hyperglycemia; a microarray wherein the antibody or the aptamer to be bound to the marker peptide for determining the risk of hyperglycemia has been immobilized onto a carrier; a method of determining the risk of hyperglycemia wherein an amount or the presence/absence of the marker peptide for determining the risk of hyperglycemia is measured in a biological sample collected from a subject; and a kit for determining the risk of hyperglycemia comprising the antibody or the aptamer, or the microarray.
    Type: Application
    Filed: December 10, 2013
    Publication date: October 8, 2015
    Applicant: LION CORPORATION
    Inventors: Chiyoko Uchiyama, Kei Kurita
  • Patent number: 9144556
    Abstract: It is an object of the present invention to provide a composition containing lactoferrin and another component and having a prominent effect of promoting visceral lipolysis. That is, the present invention is a composition for promoting the lipolysis; a food product, a feedstuff or a pharmaceutical product including (A) lactoferrin and (B) one or more ingredients selected from the group consisting of a Durvillaea extract, raspberry ketone, an artichoke leaf extract, a rosemary extract, isoflavone, a grape seed extract, a pine bark extract, a Coleus forskohlii extract, and a cacao extract. Also provided is a method of giving the effect of promoting the lipolysis to the food product or the feedstuff by adding the component (A) and the component (B) for promoting the lipolysis to the food product or the feedstuff.
    Type: Grant
    Filed: January 20, 2012
    Date of Patent: September 29, 2015
    Assignee: LION CORPORATION
    Inventors: Noriyuki Suzuki, Michiaki Murakoshi, Tomoji Ono, Chikako Fujisaki
  • Patent number: 9119827
    Abstract: Disclosed is an ophthalmic composition which is characterized by containing (A) a vitamin A, (B) a polyoxyethylene polyoxypropylene glycol, and (C) an oil component that is selected from the group consisting of castor oil, soybean oil, sesame oil, peanut oil, olive oil, almond oil, wheat germ oil, corn oil, rapeseed oil, sunflower oil, purified lanolin and gel hydrocarbon.
    Type: Grant
    Filed: June 29, 2010
    Date of Patent: September 1, 2015
    Assignee: LION CORPORATION
    Inventors: Akito Odaka, Chieko Inoue, Manabu Hattori, Nobuhito Tabuchi
  • Publication number: 20150160239
    Abstract: It is an object of the present invention to provide a marker substance capable of accurately determining a risk of developing metabolic syndrome in vivo. That is, the present invention provides the followings: a marker peptide for determining the risk of developing the metabolic syndrome; an antibody or an aptamer bound to the marker peptide for determining the risk of developing the metabolic syndrome; a microarray in which the antibody or the aptamer bound to the marker peptide for determining the risk of developing the metabolic syndrome has been immobilized on a carrier; a method for determining the risk of developing the metabolic syndrome, comprising measuring an amount or the presence or absence of the marker peptide for determining the risk of developing the metabolic syndrome in a biological sample collected from a subject; and a kit for determining the risk of developing the metabolic syndrome, comprising the antibody or the aptamer or comprising the microarray.
    Type: Application
    Filed: December 27, 2012
    Publication date: June 11, 2015
    Applicant: LION CORPORATION
    Inventors: Chiyoko Uchiyama, Kei Kurita, Eriko Fukushima, Riichi Maki